**6. Conclusion**

Dermatological pathologies are increasingly common and often have a chronic nature, resulting in a real challenge to owners and veterinaries. This leads to animals having to receive long-term or lifelong medications with its consequent systemic side effects. Veterinary regenerative medicine is an area field of research that is becoming more explored and active. Therefore, in the recent years, there have been significant advances in developing effective and safe stem cell therapies. Those studies reveal that MSCs have anti-inflammatory, anti-apoptotic, anti-fibrotic, and immunomodulatory potential, which ensures success in the treatment of degenerative, immunological, and inflammatory diseases in animals. In this review, some relevant cited studies in the field of veterinary dermatology demonstrated better results in the treatment of chronic wounds, especially with the use of UC-MSCs and ADSCs. These studies also showed accelerated wound healing in different clinical conditions. Although more studies are still necessary in this regard, the use of MSCs seems to be a very promising and safe therapeutic option.
